Physiological Axis · 18 Therapeutic Axes
Therapeutic R&D Matrix
Live pharmacokinetic research across 10 therapeutic axes. Each cluster represents a science-backed manufacturing capability ready for market deployment.
Evidence-First
PubMed-Backed Research
Every formulation axis is cross-referenced with the U.S. National Library of Medicine database — updated monthly by our automated pipeline.
AI-Verified
Elicit Research Intelligence
Semantic search across 125M+ peer-reviewed papers surfaces the strongest efficacy and safety evidence for each therapeutic cluster.
B2B Only
CDMO Formulation Intelligence
Each dossier is engineered for pharma and nutraceutical brands — not end consumers. Strict zero conflict-of-interest policy.
Evidence-Based Medicine
The Science of Formulation: Our Commitment to Evidence-Based Medicine
At Olympia Biosciences—a premier global Contract Development and Manufacturing Organization (CDMO) proudly rooted in Poland—we believe that world-class health solutions begin with uncompromising scientific rigor. As a dedicated, pure-play B2B partner, we do not own, market, or sell proprietary consumer brands. Our sole mission is to serve as the scientific and operational powerhouse behind the world's elite doctor-led brands and healthcare enterprises that demand the highest standards of quality, safety, and Evidence-Based Medicine (EBM).
Why We Publish Independent Scientific Literature
Behind every formulation we engineer stands a multidisciplinary team of medical doctors, biotechnologists, and research scientists. While we strictly adhere to global regulatory frameworks—routinely equipping our partners with comprehensive, EFSA-compliant claim declarations—we also recognize a fundamental reality of modern healthcare: the pace of clinical discovery frequently outstrips the speed of institutional updates.
We hold the utmost respect for global regulatory authorities, yet for our team, basic compliance is merely the baseline. We proactively analyze emerging peer-reviewed data because we must be absolutely certain that every formulation we develop is fundamentally safe, highly bioavailable, and unequivocally effective within its targeted scope.
The independent medical and scientific reviews published on our platform are general overviews, not tied to any specific commercial product. They reflect our mandate to champion the science that drives the industry forward. By bridging the gap between cutting-edge academic research and commercial manufacturing, Olympia Biosciences empowers your brand to deliver market-leading products defined by genuine scientific integrity.
13 Research Categories · Click to Filter
Your Specialty. Your Research.
From phlebology to oncology, from GMP compliance to bioavailability engineering — select your field and filter dossiers below.
Therapeutic Specialties
CDMO Technology Capabilities
18 Therapeutic Axes · Live Research
Formulation Dossiers
Precision Microbiome & Gut-Brain Axis
Your Gut Bacteria Are Hijacking Your ADHD Brain — The Dopamine-Microbiota Mechanism Explained
Developing scientifically validated microbiome-targeted interventions for ADHD involves addressing the challenges of heterogeneity in clinical outcomes and identifying precise microbial mechanisms. Formulating stable, effective probiotics or synbiotics with demonstrated clinical benefits remains a major hurdle.
Advanced BBB Permeability Solutions
Can Lipid Nanoformulations Unlock the Blood-Brain Barrier?
Lipophilic phytochemicals exhibit poor systemic and brain bioavailability due to rapid metabolism, low solubility, and active efflux at the blood-brain barrier, impeding clinical translation.
Post-GLP-1 Metabolic Optimization
Fixing Ratio Variability in Solid Oral Formulations
Fixed-ratio solid oral formulations are prone to content uniformity failures caused by segregation during handling and compression, exacerbated by moisture-driven changes in material properties. These challenges impact dosing accuracy and lead to potential batch rejection.
Female Endocrine-Metabolic Crosstalk
Combat Household Xenoestrogens with Precision Nutrition
Designing medical foods that mitigate the effects of chronic, low-dose exposure to diverse endocrine-disrupting chemical mixtures, while adhering to regulatory definitions and ensuring compatibility with polypharmacy risks.
Precision Microbiome & Gut-Brain Axis
Breakthrough in Gut-Brain Butyrate Delivery
Free butyrate salts dissolve prematurely in the upper gastrointestinal tract, limiting their availability for distal gut signaling. Additionally, their pungent odor and taste present significant challenges for patient adherence in chronic applications.
Cellular Longevity & Senolytics
Protecting Thermolabile Longevity Compounds in Manufacturing
High-shear unit operations and thermal processing subject sensitive longevity compounds to degradation via thermal, oxidative, and mechanical stress. Maintaining compound stability while preserving efficacy during manufacturing requires advanced stabilization and protection strategies.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Is a Ketogenic Diet the Key to Neuroprotection?
Developing a formulation that achieves consistent and measurable ketosis while optimizing bioavailability and tolerability in neurodegenerative conditions is a key challenge.
Intracellular Defense & IV-Alternatives
Moisture-Proofing Fixed-Ratio Formulations
Fixed-ratio solid formulations are prone to segregation during manufacturing, especially under moisture-driven property changes, causing dose uniformity and accuracy challenges.
Intracellular Defense & IV-Alternatives
Real-Time Raman Solutions for Botanical APIs
Ensuring real-time quality control of botanical APIs is hindered by the need to detect trace contaminants, such as pesticide residues or adulterants, in heterogeneous botanical matrices while meeting regulatory sensitivity requirements.
Cellular Longevity & Senolytics
Can Nutraceutical Matrices Reverse Cellular Senescence?
Developing a nutraceutical matrix that precisely modulates senescence-related biomarkers requires integrating senolytic activity, SASP suppression, and mitochondrial restoration within a single formulation while ensuring in vitro reproducibility and scalability.
Intracellular Defense & IV-Alternatives
Solve Oxidative Stress in Nutraceutical Stability
Nutraceutical dosage forms face significant degradation due to oxidative stress, driven by moisture, oxygen, and light. This presents a challenge for maintaining stability across supply-chain conditions and long shelf lives.
Cellular Longevity & Senolytics
Polymeric-Matrix Senolytics: Breakthroughs in Bioavailability
Orally administered senolytic compounds often suffer from poor pharmacokinetics, including low and variable bioavailability, rapid metabolism, pH-dependent dissolution, and limited cellular bioaccessibility.
Post-GLP-1 Metabolic Optimization
Semaglutide: GI Effects, Weight Regain & New Insights
Developing GLP-1 formulations that balance robust metabolic benefits with reduced gastrointestinal side effects and mitigate post-discontinuation weight regain remains a significant challenge. The interplay between appetite modulation, gastrointestinal motility, and adverse event profiles adds complexity to product optimization.
Intracellular Defense & IV-Alternatives
Safer Intrapartum Nutrition: Novel Hydrogel Beats Delayed Gastric Emptying
Developing a carbohydrate formulation for active labour is challenging due to delayed gastric emptying, high aspiration risk, and the need to prevent maternal and neonatal dysglycemia. Current oral options are inadequate, often necessitating IV administration.
Precision Microbiome & Gut-Brain Axis
Unlocking the Dietary Influence on Mental Health
Optimal dietary interventions for psychiatric disorders remain poorly standardized and show high variability in effectiveness.
Cellular Longevity & Senolytics
Unlock Max Potency: Stabilizing Longevity Compounds Under Manufacturing Stress
Thermolabile longevity-associated compounds face significant thermal, oxidative, pH, and mechanical stresses during high-shear manufacturing processes. These combined stressors accelerate chemical degradation, leading to reduced delivered potency and efficacy.
Cellular Longevity & Senolytics
Unlock Fisetin's Full Power: Nano-Micellar Senolytic Delivery
Hydrophobic senolytic flavonoids like fisetin and quercetin face significant bioavailability challenges due to poor aqueous solubility, limiting their therapeutic potential. Conventional formulations fail to achieve adequate systemic exposure for effective cellular senescence clearance.
Glycolysis-Restricted FSMP (Oncology Nutrition)
The Glucose Paradox: Is Your Oncology Nutrition Doing More Harm Than Good?
Formulating oncology-specific medical foods that balance caloric adequacy with metabolic compatibility is challenging, as standard high-glycemic carbohydrate profiles can inadvertently fuel tumor progression and worsen cachexia in vulnerable patients.
🔬
R&D Request
We haven't published this dossier yet.
Submit your research topic below — completely free. If we develop it, you'll be the first to know. Leave your contact so we can reach out when the dossier is ready.
Shape Our Research Agenda
Didn't find your research topic?
Tell us what formulation science challenge you're working on. We review every suggestion — if we develop the dossier, we'll notify you first. No cost. No commitment. Just science.
✓ Free ✓ Reviewed by Olimpia Baranowska ✓ You'll be first to receive the dossier
18
Published Dossiers
13
Research Categories
125M+
Papers Indexed via Elicit
100%
Client IP Ownership
Full Research Coverage
Every category links directly to the relevant dossiers. Click any row to filter the article grid above.
Science Newsletter
New R&D Article Every Week
Get Olimpia's latest therapeutic research insights delivered straight to your inbox. B2B formulators & pharma scientists only.
No spam. Unsubscribe anytime. One email per week.
Our IP Pledge
We do not own consumer brands. We never compete with our clients.
Every formula engineered at Olympia Biosciences™ is built from scratch and transferred to you with full intellectual property ownership. Zero conflict of interest — guaranteed by ISO 27001 cybersecurity and ironclad NDAs.